Prion diseases are rare, deadly neurodegenerative brain diseases that result from misfolding protein. Recent study encourages the development of antibodies to PrPC to prevent its conversion to PrPSc. If successful, their unique approach illuminates treatment for prion and other like diseases
Subscribe to:
Post Comments (Atom)
-
Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...
-
The following is a guest article by Ladd Wiley, Senior Vice President for Global Corporate Affairs, Public Policy, and Advocacy at Epic , ...
-
Robert Connely of Pega says patching legacy systems will give way to true health IT modernization, a security breakthrough will lead artific...
No comments:
Post a Comment